FIAT, the factor-inhibiting ATF4-mediated transcription, also represses the transcriptional activity of the bZIP factor FRA-1

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 338-343

  St Arnaud, René ^a,b   Mandic, Vice ^a,b   Elchaarani, Bilal ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

AP 1; ATF4; C JUN; FIAT; FRA 1; Osteoblast; Transcriptional repression

Indexed keywords

BASIC DOMAIN LEUCINE ZIPPER; FACTOR INHIBITING ATF4 MEDIATED TRANSCRIPTION; GELATINASE B; LEUCINE ZIPPER PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG;

CONFERENCE PAPER; PROTEIN INTERACTION;

EID: 77950684784     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05211.x     Document Type: Conference Paper

References (40)

1. Landschulz, W.H., P.F. Johnson & S.L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759-1764.
2. Glover, J.N. & S.C. Harrison. 1995. Crystal structure of the heterodimeric bZIP transcription factor c-Fos- c-Jun bound to DNA. Nature 373: 257-261.
3. Hartl, M.,A.G.Bader& K.Bister. 2003.Molecular targets of the oncogenic transcription factor jun. Curr. Cancer Drug Targets 3: 41-55. (Pubitemid 36119420)
4. Vinson,C., M.Myakishev, A.Acharya, et al. 2002. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell Biol. 22: 6321-6335.
5. Vallejo, M., D. Ron, C.P. Miller, et al. 1993. C/ATF, a member of the activating transcription factor family of DNA- binding proteins, dimerizeswithCAAT/enhancerbinding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90: 4679-4683. (Pubitemid 23148969)
6. Hai, T. & T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720-3724. (Pubitemid 21916695)
7. Chevray, P.M. & D. Nathans. 1992. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc.Natl. Acad. Sci. USA 89: 5789-5793.
8. Wagner, E.F. 2002. Functions of AP1 (Fos/Jun) in bone development. Ann. Rheum. Dis. 61(Suppl 2): ii40-42.
9. Yang, X. & G. Karsenty. 2002. Transcription factors in bone: developmental and pathological aspects. Trends Mol. Med. 8: 340-345. (Pubitemid 34733388)
10. Hettmann, T., K. Barton & J.M. Leiden. 2000. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev. Biol. 222: 110-123. (Pubitemid 30387733)
11. Masuoka, H.C. & T.M. Townes. 2002. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 99: 736-745.
12. Tanaka, T., T. Tsujimura, K. Takeda, et al. 1998. Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres. Genes Cells 3: 801-810. (Pubitemid 29098936)
13. Yang, X., K. Matsuda, P. Bialek, et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117: 387-398. (Pubitemid 38534544)
14. Elefteriou, F., J.D. Ahn, S. Takeda, et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520. (Pubitemid 40477060)
15. Trivier, E., D. De Cesare, S. Jacquot, et al. 1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384: 567-570. (Pubitemid 26415934)
16. Elefteriou, F., M.D. Benson, H. Sowa, et al. 2006. ATF4 mediation ofNF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. CellMetab. 4: 441-451. (Pubitemid 44817348)
17. Jochum, W., J.P. David, C. Elliott, et al. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat.Med. 6: 980-984.
18. Eferl, R., A. Hoebertz, A.F. Schilling, et al. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23: 2789-2799. (Pubitemid 39013551)
19. Sabatakos, G., N.A. Sims, J. Chen, et al. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6: 985-990.
20. Sims, N.A., G. Sabatakos, J.S. Chen, et al. 2002. Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass. Bone 30: 32-39. (Pubitemid 34044298)
21. Matsuo, K., J.M. Owens, M. Tonko, et al. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24: 184-187. (Pubitemid 30094722)
22. Vial, E.& C.J.Marshall. 2003. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell Sci. 116: 4957-4963. (Pubitemid 38016702)
23. Yang, X. & G. Karsenty. 2004. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in nonosteoblastic cells. J. Biol. Chem. 279: 47109-47114. (Pubitemid 39518367)
24. Gruda, M.C., K. Kovary, R.Metz, et al. 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9: 2537-2547. (Pubitemid 24254029)
25. Chinenov, Y. & T.K. Kerppola. 2001. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452. (Pubitemid 32531301)
26. Fawcett, T.W., J.L. Martindale, K.Z. Guyton, et al. 1999. Complexes containing activating transcription factor (ATF)/cAMP- responsive-element- binding protein (CREB) interact with the CCAAT/enhancerbinding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem. J. 339: 135-141.
27. Lim, C., H. Sohn, Y. Gwack, et al. 2000. Latencyassociated nuclear antigen of Kaposi's sarcomaassociated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81: 2645-2652.
28. Yu, V.W. C., C. Gauthier & R. St-Arnaud. 2006. Inhibition of ATF4 transcriptional activity by FIAT/γ-taxilin modulates bone mass accrual. Ann. N.Y. Acad. Sci. 1068: 131-142. (Pubitemid 43824144)
29. Yu, V.W., G. Ambartsoumian, L. Verlinden, et al. 2005. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169: 591-601.
30. Yu, V.W., J. El-Hoss & R. St-Arnaud. 2009. FIAT inhibition increases osteoblast activity by modulating Atf4-dependent functions. J. Cell. Biochem. 106: 186-192.
31. Yu, V.W., C. Gauthier & R. St-Arnaud. 2008. FIAT represses bone matrix mineralization by interacting with ATF4 through its second leucine zipper. J. Cell. Biochem. 105: 859-865.
32. St-Arnaud, R. & B. Elchaarani. 2007. Identification of additional dimerization partners of FIAT, the factor inhibiting ATF4-mediated transcription. Ann. N.Y. Acad. Sci. 1116: 208-215.
33. Ayala, J.E., J.N. Boustead, S.C. Chapman, et al. 2004. Insulin-mediated activation of activator protein-1 through the mitogen-activated protein kinase pathway stimulates collagenase-1 gene transcription in the MES 13 mesangial cell line. J. Mol. Endocrinol. 33: 263-280.
34. Farzaneh-Far, A., J.D. Davies, L.A. Braam, et al. 2001. A polymorphism of the human matrix gammacarboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serumlevels. J. Biol.Chem. 276: 32466-32473.
35. Bakiri, L., K. Matsuo, M. Wisniewska, et al. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell Biol. 22: 4952-4964.
36. Cohen, D.R., P.C. Ferreira, R. Gentz, et al. 1989. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3: 173-184.
37. Wisdon, R. & I.M. Verma. 1993. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol. Cell Biol. 13: 7429-7438.
38. Kouzarides, T. & E. Ziff. 1988. The role of the leucine zipper in the fos-jun interaction. Nature 336: 646-651.
39. Schuermann, M., M. Neuberg, J.B. Hunter, et al. 1989. The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell 56: 507-516.
40. Yu, V.W., O. Akhouayri & R. St-Arnaud. 2009. FIAT is co-expressed with its dimerization target ATF4 in early osteoblasts, but not in osteocytes. Gene Expr. Patterns 9: 335-340.